Newsletter | July 10, 2026

07.10.26 -- In Palm Beach The Focus Is On Biotech (Not President Trump)

INDUSTRY INSIGHTS

Q&A | CorePharma

Gain practical perspective on emerging capabilities, common sponsor challenges, and what will matter most as the CDMO landscape continues to evolve.

Compressing Analytical Timelines Without Cutting Corners

Article | By George Wei, Experic

Efficient analytical development speeds decisions and improves risk visibility. Using QbD, digital tools, and strong communication helps teams accelerate timelines while maintaining rigor.

Secondary Packaging: Cartoning And Kitting With An Aggressive Timeline

Case Study | Praxis Packaging

Meeting tight launch timelines requires more than speed. Smart kit design, controlled production workflows, and scalable processes come together to deliver complex packaging programs quickly.

FEATURED EDITORIAL

In Palm Beach The Focus Is On Biotech (Not President Trump)

By Louis Garguilo, Chief Editor, Outsourced Pharma

“When I came to Florida,” James Sapirstein says, “I was leaving New Jersey because of tax reasons.” That was 2018. Timing is everything, they say. Sapirstein’s relocation placed him ahead of a broadening and intensifying migration trend – including he believes, a new biotechnology settlement. This is not news to readers – Miami alone seems perennially in the headlines. “Economics drives investors,” Sapirstein says, and he is committed to spearheading “a new kind of biotech cluster."

Achieving Annex 1 Compliance In Sterile Manufacturing, Part 2: Objective Measurement Tools

By Bikash Chatterjee, President and CSO of Pharmatech Associates, a USP Company and USP Microbiology

Let's examine the objective measurement tools that directly address each of the gaps between Annex 1 expectations and what drug manufacturing facilities can currently demonstrate in practice.

INDUSTRY INSIGHTS CONTINUED

Coordinated Development As An Execution Framework

White Paper | Thermo Fisher Scientific

See how integrating clinical, development, manufacturing, and supply functions within a single execution framework can transform program performance and accelerate development success.

T3P – A Green Solution For Peptide Coupling, Water Removal Reactions

Webinar | Curia

The session focuses on the use of T3P (propanephosphonic acid anhydride) in amidation and peptide coupling reactions, including both liquid-phase and solid-phase peptide synthesis.

Spray Drying For Combination Dry Powder Inhaler Formulations

White Paper | By Kimberly B. Shepard, Amanda M. Pluntze, and David T. Vodak, Lonza

Three combination case studies are demonstrated, in which bevacizumab is paired with erlotinib, cisplatin, or paclitaxel in a dry powder inhaler formulation.

Optimizing The Path From First-In-Human To Proof-Of-Concept

Article | By Matt Paterson, Quotient Sciences

By collapsing the gaps between manufacturing and clinical trials and integrating these functions into a unified system, teams can adjust formulations in real-time and accelerate timelines.

SOLUTIONS

Optimizing Containment And Scaling In Highly Potent Drug Manufacturing

Bend Bioscience

Your Integrated Drug Substance Partner

Grace Fine Chemical Manufacturing Services

Process Development And Preclinical Manufacturing — India

Pharma Expanse

OUTSOURCED PHARMA CAPABILITIES UPDATE

Find Your New CDMO At Outsourced Pharma Capabilities Update

CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capabilities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs.

Connect With Outsourced Pharma: